Dr. Christopher Lao, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Mi Hosps And Health Ctrs

  Residency Hospital

• City University Of New York School Of Medicine

  Medical School, 1998

• Concurrent whole brain radiotherapy and bortezomib for brain metastasis, 2013-08-21

• Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma, 2015-05-31

• Dose escalation of a curcuminoid formulation, 2006-03-17

• Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes, 2022-07-27

• Metastatic Merkel cell carcinoma response to nivolumab, 2016-11-15

• Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512, 2012-11-30

• Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study, 2011-11-30

• Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (S0438), 2012-01-06

• Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma, 2021-11-24

• Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study, 2021-11-10

• Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain, 2018-08-23

• Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma, 2022-09-23

• A multi-center study of high dose Aldesleukin (Proleukin®(HD IL-2) + Vemurafenib Zelboraf®) therapy in patients with BRAFV600mutation positive metastatic melanoma (proclivity 01), 2014-11-06

• Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination, 2021-01-04

• Implications of age and conditional survival estimates for patients with melanoma, 2016-09-04

• Effect of Selumetinib versus Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial, 2014-06-18

• Erratum to: Metastatic Merkel cell carcinoma response to nivolumab, 2017-03-06

• Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab, 2022-07-06

• Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study, 2017-05-16

• Relationship between Physician-Adjudicated Adverse Events and Patient-Reported Health-Related Quality of Life in a Phase II Clinical Trial (NCT01143402) of Patients with Metastatic Uveal Melanoma, 2016-12-05